Hepatic Steatosis Index Is Associated with Type I Diabetes Complications

被引:17
|
作者
Tripolino, Cesare [1 ]
Irace, Concetta [2 ]
Cutruzzola, Antonio [2 ]
Parise, Martina [1 ]
Barone, Milena [1 ]
Scicchitano, Caterina [1 ]
Cortese, Claudio [3 ]
Gnasso, Agostino [1 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Clin & Expt Med, Metab Dis Unit, Catanzaro, Italy
[2] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy
[3] Tor Vergata Univ, Dept Expt Med & Surg, Rome, Italy
关键词
fatty liver; type; 1; diabetes; diabetes complications; FATTY LIVER-DISEASE; ADULT PATIENTS; PREVALENCE;
D O I
10.2147/DMSO.S221969
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several biochemical indexes of NAFLD have been developed. Among these, hepatic steatosis index (HSI) strongly relates with the results of magnetic resonance. Aim: The aim of the present study was to evaluate the possible association between HSI and complications in T1DM. Methods: Medical records of patients with T1DM were evaluated. Macro- and microvascular complications were evaluated by a combination of instrumental (ECG, carotid artery echo-Doppler, fundus examination, vibration threshold at biothesiometry) and laboratory examination. HSI was calculated based on gender, body mass index and transaminases level. Results: Of the 124 patients evaluated, 71 were free of complications and 53 had at least one complication. The prevalence of diabetes complications was: 27% for retinopathy, 15% for carotid atherosclerosis, 16% for neuropathy. HSI was directly correlated with age, disease duration, triglycerides, total daily insulin and inversely with HDL and eGFR. In logistic regression analysis, HSI was independently associated with diabetic complications. Conclusion: These findings show that HSI is independently associated with the presence of complications in subjects with T1DM. This can be of clinical utility, allowing a better diagnostic classification of the patient and possibly guiding the therapeutic choice.
引用
收藏
页码:2405 / 2410
页数:6
相关论文
共 50 条
  • [21] Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes
    Sviklane, Laura
    Olmane, Evija
    Dzerve, Zane
    Kupcs, Karlis
    Pirags, Valdis
    Sokolovska, Jelizaveta
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (01) : 270 - 276
  • [22] Dietary Inflammatory Index Associated with Complications in Long Duration Type 1 Diabetes
    Shah, Hetal
    Wolfson, Emily
    Yu, Marc Gregory
    Adam, Atif
    Hu, Frank
    King, George L.
    DIABETES, 2020, 69
  • [23] High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus
    Gupta, Aanchal
    Anoop, Shajith
    Ansari, Irshad Ahmad
    Prakash, Satya
    Misra, Anoop
    CLINICAL NUTRITION ESPEN, 2021, 46 : 519 - 526
  • [24] The Relationship Between Diabetes, Body Mass Index and Hepatic Steatosis: Only Insulin Dependent Diabetes is a Risk Factor for Major Complications after Liver Resection
    Wiggans, M. G.
    Shahtahmassebi, G.
    Aroori, S.
    Bowles, M. J.
    Stell, D. A.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 291 - 291
  • [25] An index of activity of stearoyl-coa desaturase high is associated with steatosis in patients with type 2 diabetes
    Petit, J. M.
    Guiu, B.
    Athias, A.
    Duvillard, L.
    Brindisi, M. C.
    Crevisy, E.
    Buffier, P.
    Robin, I.
    Gambert, P.
    Hillon, P.
    Cercueil, J. P.
    Verges, B.
    DIABETES & METABOLISM, 2010, 36 : A35 - A35
  • [26] HEPATIC STEATOSIS IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE
    Adrian, Therese
    Hornum, Mads
    Knop, Filip K.
    Almdal, Thomas Peter
    Rossing, Peter
    Lida, Lisa
    Heinrich, Niels Sondergaard
    Boer, Vincent
    Marsman, Anouk
    Petersen, Esben
    Siebner, Hartwig
    Feldt-Rasmussen, Bo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I294 - I294
  • [27] Hepatic ATP levels and steatosis in obese patients with type 2 diabetes
    Solga, SF
    Clark, JM
    Horska, A
    Diggs, C
    Shields, T
    Brancati, F
    Diehl, AM
    GASTROENTEROLOGY, 2004, 126 (04) : A755 - A755
  • [28] Hepatic Steatosis and Low Cardiorespiratory Fitness in Youth With Type 2 Diabetes
    Wittmeier, Kristy D. M.
    Wicklow, Brandy A.
    MacIntosh, Andrea C.
    Sellers, Elizabeth A. C.
    Ryner, Lawrence N.
    Serrai, Hacene
    Gardiner, Philip F.
    Dean, Heather J.
    McGavock, Jonathan M.
    OBESITY, 2012, 20 (05) : 1034 - 1040
  • [29] Hepatic steatosis and Type 2 diabetes: current and future treatment considerations
    Richard, John
    Lingvay, Ildiko
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2011, 9 (03) : 321 - 328
  • [30] Evaluation of Hepatic Steatosis and Adiposity in People with Type 1 Diabetes and Obesity
    Trikudanathan, Subbulaxmi
    Amin, Kathan
    Bambha, Kiran
    Melhorn, Susan J.
    Sekhon, Mandeep
    Navarro, Sandi
    Schur, Ellen A.
    Hirsch, Irl B.
    DIABETES, 2024, 73